Angiochem Inc. logo
Portfolio company

Angiochem Inc.

Details
Region
Quebec
Industry sector
Drugs
Investment year
2005
Fund
Healthcare Venture Fund
Learn more
Our partnership

AngioChem is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Bharat Srinivasa, Principal at Amplitude Venture Capital

About the company

Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough drugs that are leveraging the LRP-1 mediated pathway to cross the blood-brain barrier (BBB) to treat brain diseases.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.